Featured Research

from universities, journals, and other organizations

Elevated Arginase Levels Contribute To Vascular Eye Disease Such As Diabetic Retinopathy

Date:
August 24, 2009
Source:
Medical College of Georgia
Summary:
Elevated levels of the enzyme arginase contribute to vascular eye damage and researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.

Drs. Wenbo Zhang (from left), Ruth Caldwell and R. William Caldwell have shown that elevated levels of the enzyme arginase contribute to vascular eye damage in diseases such as diabetic retinopathy.
Credit: Medical College of Georgia

Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.

Their work, published in the August issue of The American Journal of Pathology, is the first to make the connection between eye disease and arginase, an enzyme known to be a player in cardiovascular disease, according to researchers at MCG and Charlie Norwood Veterans Affairs Medical Center.

"The goal is to find a new strategy for preventing progression of diabetic retinopathy," says Dr. Ruth Caldwell, a cell biologist at the MCG School of Medicine and VA Medical Center, and the study's corresponding author.

Because they could measure arginase levels in the blood, it also could become a biomarker for a disease process that can work silently in the eye for months or even years, she says.

More broadly, understanding just how arginase regulates inflammation should lead to new therapies for many acute and chronic inflammatory diseases in the eyes and other organs, says Dr. Wenbo Zhang, postdoctoral fellow in Dr. Caldwell' lab and the paper's first author.

The researchers suspect an elevated arginase level is a red flag of early vascular damage in the eyes as well as the heart, kidneys and other organs. "We don't think this is going to be specific to the retina," Dr. Caldwell says, noting that inflammation often precedes full blown vascular disease.

"We know that people with diabetes have a greater incidence of heart attack and we know that vision is a sense that suffers greatly in diabetes," says Dr. R. William Caldwell, study co-author who chairs the Department of Pharmacology and Toxicology in the MCG School of Medicine. "We are finding arginase is a common player."

To create an animal model of the inflammation that occurs early in vascular eye disease, they used bacterial proteins to produce a severe and rapid inflammation of the eye called uveitis, which can also cause blindness but is easier to detect and treat than diabetic retinopathy.

"Inflammation of the blood vessel walls in the retina is some of the earliest eye damage that occurs in diabetes. This is like hitting the same system with a sledge hammer," Dr. Ruth Caldwell says. Short term, inflammation causes redness and irritation as it lays the groundwork for an unhealthy remodeling of blood vessel walls that restricts blood flow.

Inside the diabetic eye, high glucose levels trigger inflammation and, in an apparent effort to fight it, arginase actually ends up contributing to inflammation and vascular disease as well. The crux of the problem seems to be too much competition for L-arginine, an amino acid arginase requires to take any action – good or bad, says Dr. William Caldwell.

The retina, located at the back of the eye, is essentially an extension of the brain that receives light and transforms it to a neural impulse that travels back to the brain via the optic nerve. It can withstand assaults, such as elevated glucose levels that occur in diabetes, for years before vascular cells become damaged and die. That destruction spurs development of new blood vessels to deliver oxygen to oxygen-starved tissue but instead the proliferation blocks vision and they leak, increasing retinal damage.

Early in the diabetic process, high levels of glucose trigger high levels of inducible nitric oxide synthase, which makes nitric oxide. Under conditions of acute inflammation, nitric oxide helps control injury by killing off invaders. But during diabetes, it increases oxidative stress, causing further tissue damage. As part of the fight, arginase increases to provide substrates for tissue repair and to dampen the actions of inducible nitric oxide synthase. The complicating news is that nitric oxide synthase in endothelial cells, which makes the nitric oxide that enables blood vessels to relax, also is competing with arginase for the L-arginine.

The net effect can be too little nitric oxide inside blood vessel walls to help them relax and keep white blood cells and platelets from sticking to them.

"It's taking L-arginine away from the nitric oxide synthase so it can accelerate wound healing but the lack of substrate for nitric oxide synthase leads to vascular constriction and occlusion which causes further tissue damage, " Dr. Ruth Caldwell says. The researchers, who also are studying this process in a model of diabetic retinopathy, want to fully delineate the complex scenario. They already know high levels of the signaling molecule reactive oxygen species is another factor. As with arginase, some reactive oxygen species formation is a good thing but too much causes blood vessel damage.

"Our studies demonstrate that if we inhibit arginase, we also reduce the reactive oxygen species level and vice versa," Dr. Zhang says. "It appears that arginase and nitric oxide synthase influence each other in a positive feedback loop."

Rather than drugs that generally suppress arginase, the researchers want to find new drugs that can restore healthy levels of arginase. "You need arginase. If you don't have it, you are in big trouble," says Dr. William Caldwell. "We want to delineate the events that cause elevation and limit the elevation to prevent the resulting pathology."

The only U.S. Food and Drug Administration approved therapy to intervene in diabetic retinopathy is to use lasers to burn holes in the retina, which reduces the oxygen needs of the tissue by destroying some of it.

In related studies, Dr. William Caldwell, in conjunction with Dr. Maritza Romero, MCG assistant research scientist, has shown that in diabetes blood vessels throughout the body suffer from too much competition for L-arginine and that another amino acid, L-citrulline, as well as statin drugs used to treat cholesterol can prevent unhealthy elevation of arginase.


Story Source:

The above story is based on materials provided by Medical College of Georgia. Note: Materials may be edited for content and length.


Cite This Page:

Medical College of Georgia. "Elevated Arginase Levels Contribute To Vascular Eye Disease Such As Diabetic Retinopathy." ScienceDaily. ScienceDaily, 24 August 2009. <www.sciencedaily.com/releases/2009/08/090818130431.htm>.
Medical College of Georgia. (2009, August 24). Elevated Arginase Levels Contribute To Vascular Eye Disease Such As Diabetic Retinopathy. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2009/08/090818130431.htm
Medical College of Georgia. "Elevated Arginase Levels Contribute To Vascular Eye Disease Such As Diabetic Retinopathy." ScienceDaily. www.sciencedaily.com/releases/2009/08/090818130431.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins